Purpose - To examine the knowledge of schizophrenic inpatients regarding th
eir medication.
Methods - Fifty male and 50 female patients with schizophrenia were intervi
ewed before discharge from the University Psychiatric Hospital in Ljubljana
, Slovenia. Socio-demographic and clinical data were collected and the Glob
al Assessment Scale (GAS) was used. Patients were asked to give the name, p
urpose and adverse effects of their prescribed drugs.
Results - The mean age of the patients was 40.0 years and they had, on aver
age, 6.9 admissions. Their mean GAS score was 58.5, indicating moderately i
mpaired everyday functioning. The majority of patients were prescribed two
to four psychotropic drugs. Most patients (87.0%) could name the antipsycho
tic, 77.0% knew the purpose of their medication and 65.0% knew its side-eff
ects. The same was true for the name (90.3%) and purpose (77.0%) of the ant
icholinergic, but its side-effects were less well known (28.9%). The name o
f the hypnotic was known to 76.5% patients, the purpose to 90.6% and its si
de-effects to 34.4%. Only 58% of patients had ever requested information on
their medication. The majority of patients received information from packa
ge inserts (35%) or from psychiatrists (29%). Most patients (55%) were sati
sfied with the information.
Conclusions - The information on medication among patients is insufficient.
Clinicians should regularly offer and repeat relevant information. Copyrig
ht (C) 2000 John Wiley & Sons, Ltd.